1. HBW Insight

Artificial Intelligence: CDER’s New Council Takes Charge Of Oversight, Coordination

 
• By Sue Sutter

The Artificial Intelligence Council takes over work that three different entities in the US FDA’s drugs center had been performing. The new, centralized entity will develop and promote consistency in AI-related activities and advance innovative uses.

Chess piece
• Source: Shutterstock

The US FDA’s Center for Drug Evaluation and Research is consolidating oversight and coordination of all internal and external artificial intelligence efforts into one centralized entity.

Key Takeaways

  • CDER’s Artificial Intelligence Council will coordinate and oversee all AI activities.

  • The single, centralized council will replace three different entities

The new Artificial Intelligence Council will coordinate, develop, support and promote consistency in AI-related activities throughout the drugs

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Digital Technologies

More from HBW Insight